PQT/VCP May Update
VCP
Two additional MPXV tests listed by WHO under the Emergency Use Listing procedure
IVD
We are pleased to announce that two additional MPXV tests have been listed under WHO's Emergency use listin
Join us for Informative webinar on the latest new WHO guidance on reportable changes to WHO PQ and EUL IVDs_19 May 2025
IVD
Dear colleagues,
You are invited to a Zoom webinar.
An additional HIV RDT was prequalified by WHO
IVD
The professional use only version of
WHO prequalified the first HIV-1 self-test by Urine
IVD
The WANTAI HIV SELF TEST BY URINE Rapid Urine Test for Detection of Antibody to Human Immunodeficiency Vir
Publication of updated Guidance and Application Form for Reportable changes to WHO prequalified and emergency use listed in vitro diagnostics
IVD
WHO is pleased to announce the publication of the revised guidan
Prequalification of IVDs scope expanded to haemoglobin PoC analysers
IVD
WHO is pleased to announce that the Prequalification of in vitro diagnostics programme has been expanded to point-of-care analysers intended for:
Active Pharmaceutical Ingredient (API) Prequalified
M
Dolutegravir (sodium) manufactured by Styrax Pharma Pvt Ltd has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
Two PQT Medicines trainings for regulators
M
The PQT Medicines Annual Quality Assessment Training for regulators will take place from 9 to 12 June 2025.